We are live on ! Find out more
Jasper Ridge Partners

Jasper Ridge Partners Portfolio holdings

AUM $4.69B Turnover 13.92%
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+31.34%
3 Year Est. Return
+84.21%
5 Year Est. Return
+70.25%
10 Year Est. Return
+324.79%
AUM
$4B
AUM Growth
+$884M
Cap. Flow
+$520M
Cap. Flow %
13.01%
Top 10 Hldgs %
82.9%
Holding
150
New
2
Increased
16
Reduced
11
Closed
2
Avg Time Held
4.8 years
Top 10 Avg Time Held
4 years
Top 20 Avg Time Held
5.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.4%
2 Technology 7.36%
3 Communication Services 3.38%
4 Financials 2.46%
5 Consumer Discretionary 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DHX icon
101
DHI Group
DHX
$211M
$637K 0.02%
214,416
– –
2015 Q4
38 quarters
PHR icon
102
Phreesia
PHR
$679M
$593K 0.01%
20,853
– –
2020 Q3
19 quarters
MQ icon
103
Marqeta
MQ
$1.95B
$555K 0.01%
23,811
+710
+3% +$13.5K
2021 Q4
14 quarters
XYZ icon
104
Block Inc
XYZ
$46.8B
$538K 0.01%
7,927
– –
2019 Q1
25 quarters
VLTO icon
105
Veralto
VLTO
$24.6B
$505K 0.01%
5,000
– –
2023 Q4
6 quarters
TXG icon
106
10x Genomics
TXG
$9.1B
$457K 0.01%
39,457
– –
2020 Q2
20 quarters
MIRM icon
107
Mirum Pharmaceuticals
MIRM
$5.2B
$418K 0.01%
8,206
– –
2023 Q4
6 quarters
BOX icon
108
Box
BOX
$5.43B
$404K 0.01%
11,814
– –
2016 Q4
34 quarters
PCOR icon
109
Procore
PCOR
$8.66B
$400K 0.01%
5,849
– –
2022 Q3
11 quarters
FOXA icon
110
Fox Class A
FOXA
$27.1B
$396K 0.01%
7,070
– –
2020 Q4
18 quarters
IQV icon
111
IQVIA
IQV
$43.9B
$388K 0.01%
2,463
– –
2018 Q3
27 quarters
AVTR icon
112
Avantor
AVTR
$11.1B
$372K 0.01%
27,606
– –
2021 Q4
14 quarters
VERA icon
113
Vera Therapeutics
VERA
$2.01B
$368K 0.01%
15,639
– –
2024 Q2
4 quarters
CRSP icon
114
CRISPR Therapeutics
CRSP
$4.76B
$363K 0.01%
7,454
– –
2019 Q2
24 quarters
AR icon
115
Antero Resources
AR
$11.9B
$360K 0.01%
8,932
– –
2022 Q1
13 quarters
CFLT icon
116
DELISTED
Confluent
CFLT
$359K 0.01%
14,409
– –
2022 Q3
11 quarters
RYTM icon
117
Rhythm Pharmaceuticals
RYTM
$5.93B
$356K 0.01%
5,639
– –
2023 Q4
6 quarters
FROG icon
118
JFrog
FROG
$10.4B
$351K 0.01%
8,000
– –
2023 Q2
8 quarters
RKT icon
119
Rocket Companies
RKT
$30.5B
$347K 0.01%
+30,991
New +$402K
2025 Q2
0 quarters
SPT icon
120
Sprout Social
SPT
$683M
$329K 0.01%
15,741
– –
2020 Q4
18 quarters
EXPE icon
121
Expedia Group
EXPE
$34.7B
$324K 0.01%
1,918
– –
2023 Q4
6 quarters
AMPL icon
122
Amplitude
AMPL
$1.84B
$285K 0.01%
23,005
– –
2022 Q3
11 quarters
ZLAB icon
123
Zai Lab
ZLAB
$2.6B
$281K 0.01%
8,024
– –
2024 Q4
2 quarters
FA icon
124
First Advantage
FA
$3.29B
$276K 0.01%
16,614
– –
2021 Q4
14 quarters
QS icon
125
QuantumScape Corp
QS
$2.48B
$254K 0.01%
37,816
– –
2021 Q2
16 quarters

Similar funds

Jasper Ridge Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Jasper Ridge Partners held 150 positions worth $4B, up 28% from $3.11B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Jasper Ridge Partners deployed $520M of net new capital in Q2 2025, opening 2 new positions and adding to 16 existing holdings. Its largest new stake was Rocket Companies: 30,991 shares worth $347K.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $27.8M trimmed.

  • Jasper Ridge Partners's largest Q2 2025 buy was Rocket Companies: 30,991 shares worth $347K.
  • Jasper Ridge Partners added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $223M increase.
  • Jasper Ridge Partners's biggest Q2 2025 reduction was iShares Russell 1000 Value ETF, cutting an estimated $27.8M.
  • Jasper Ridge Partners fully exited Redfin in Q2 2025, selling an estimated $285K.
  • Jasper Ridge Partners's ten largest holdings make up 83% of its $4B portfolio in Q2 2025.
  • Jasper Ridge Partners opened 2 new positions and closed 2 in Q2 2025.
  • Jasper Ridge Partners's portfolio value rose 28% quarter-over-quarter to $4B.

Based on Jasper Ridge Partners's 13F filing for Q2 2025, filed 14 Aug 2025.